Nirad Jain
パートナー,
Nirad
専門分野
Nirad Jain co-leads our global Healthcare Private Equity practice.
Nirad has almost 20 years of management consulting experience, partnering with corporate clients and financial investors to drive results. He has led more than 500 client engagements across the healthcare value chain, including diligence, corporate M&A, transformation, performance improvement and strategy work in the services, payer, provider, medical device and pharmaceuticals sectors.
He has built significant expertise at the intersection of private equity and healthcare and is frequently cited in the media, including appearances on Bloomberg TV, The New York Times, The Wall Street Journal, Reuters, CNBC, Forbes, Buyouts and many others around the globe.
Prior to joining Bain in 2005, Nirad worked for another consulting firm in New York, where he advised clients on growth and M&A strategies. He also previously worked in the not-for-profit sector.
Nirad holds an MBA from The Wharton School, a Master of Science from Stanford University and a Bachelor of Science, with honors, from Columbia University.
Recent Insights
- “What Differentiates Winning Healthcare IT Investments,” Global Healthcare Private Equity Report,2026年1月8日, レポート
- “Healthcare Private Equity Market 2025: Resurgence and Record Growth,” Global Healthcare Private Equity Report,2026年1月8日, レポート
- “Playing the Long Game in Pharma Services,” Global Healthcare Private Equity Report,2026年1月8日, レポート
- “New Models of Value Creation for Physician Groups,” Global Healthcare Private Equity Report,2026年1月8日, レポート
- “Deal Markets Recalibrate: Healthcare Private Equity 2025 Midyear Update,” スナップチャート, 2025年8月28日
- “Healthcare Private Equity Market 2024: Year in Review and Outlook,” Global Healthcare Private Equity Report,2025年1月9日, レポート
- “Why Mid-Market Healthcare Private Equity Firms Are Outperforming,” Global Healthcare Private Equity Report,2025年1月9日, レポート
- “Carve-Outs Open Up Value in a Tight Deal Market,” Global Healthcare Private Equity Report,2025年1月9日, レポート
- “Maximizing Exit Value: An Imperative for Both Sellers and Buyers,” Global Healthcare Private Equity Report,2025年1月9日, レポート
- “An Optimistic Growth Outlook in Asia-Pacific ,” Global Healthcare Private Equity Report,2025年1月9日, レポート
In the News
- “Global healthcare private equity hits record $190 billion deal value in 2025—Bain & Company ,” Press release, 2026年1月8日
- “Bloomberg TV: Global healthcare PE soars to $115B in 2024,” Bloomberg TV's 'The Close',2025年1月15日, Bloomberg TV's 'The Close'
- “Spurred by megadeals, global healthcare private equity deal value soared to $115 billion in 2024, the second-highest total on record,” Press release, 2025年1月9日
- “Healthcare holds its own amid a tepid deal market, reaching $60 billion in announced deal value,” Press release, 2024年1月3日
- “Down but not out: healthcare private equity deals reached nearly $90 billion in 2022, the industry’s second-biggest year on record,” Press release, 2023年4月10日